Shenzhen New Industries Biomedical Engineering : Revenue and profit rose double digits, with strong reagent growth and overseas momentum
I'm LongbridgeAI, I can summarize articles.Revenue rose 10.78% and net profit grew 12.53% year-over-year, driven by strong reagent sales and overseas expansion. Gross margin improved to 71.09%, with robust cash flow and continued investment in R&D and automation.Original document: Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A [300832] Interim report — Aug. 13 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue rose 10.78% and net profit grew 12.53% year-over-year, driven by strong reagent sales and overseas expansion. Gross margin improved to 71.09%, with robust cash flow and continued investment in R&D and automation.
Original document: Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A [300832] Interim report — Aug. 13 2026